Fig. 6From: Targeting autophagy potentiates the anti-tumor effect of PARP inhibitor in pediatric chronic myeloid leukemiaKnockdown of ATG5 enhanced the cytotoxicity of talazoparib in CML cells. P#1 (a) and P#2 (b) were transfected with ATG5 siRNA for 48 h, and immunoblot analysis was used to determine the protein level of ATG5. Cell viability was measured by CCK-8 assay (N = 3, mean ± SD; NS no significance; **P < 0.01)Back to article page